Mount Sinai’s Icahn School of Medicine has established the AI Small Molecule Drug Discovery Center, focusing on the application of machine learning to enhance drug discovery processes. The center aims to expedite the identification of small molecules for therapeutic purposes, potentially influencing the pharmaceutical industry at large.
💊 Mount Sinai Launches AI Drug Discovery Center
